Adocia S.A. | Small-cap | Healthcare

Adocia S.A Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: €6.60 High: €6.78
on August 8, 2025

52 Week Range

Low: €2.86 High: €10.96
on April 7, 2025
on November 4, 2024

All-Time High: €94.24 on July 20, 2015

Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights

Key Statistics

Market Cap i €126.1M
EPS i -0.96
P/E Ratio (TTM) i -6.69
Forward P/E i -4.99
P/B Ratio i -30.51
PEG Ratio i -4.99
Div. Yield i N/A
ROE i 301.75%
Beta i 0.312
Debt to Equity i -3.83

Financial Highlights

Profitability

Gross Margin i N/A
Operating Margin i 8.14%
Profit Margin i -76.88%

Returns and Earnings

Return on Assets (TTM) i -17.81%
Return on Equity (TTM) i 301.75%
EBITDA i €-6.9M
Net Income (TTM) i €-9.3M

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i €0.78
Quarterly Revenue Growth (YoY) i 397.20%
Quarterly Earnings Growth (YoY) i N/A

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
Adocia S.A ADOC 126.07M Small-cap0.00%74.93%69.19%24.07%4.20%16.93%28.85%-18.09%
Abivax SA ABVX 4.49B Large-cap-1.31%781.75%866.40%852.68%729.67%473.06%570.37%213.93%
Valneva SE VLA 546.93M Mid-cap21.47%55.97%33.92%12.13%64.07%21.86%-62.51%-28.63%
Ose OSE 136.49M Small-cap-3.50%23.17%3.41%-3.50%-19.52%-14.41%-15.60%6.32%
Transgene S.A TNG 133.40M Small-cap-0.99%26.58%66.67%40.85%47.06%0.00%-54.95%-31.97%
Sensorion SA ALSEN 98.61M Small-cap-6.06%-11.43%-20.51%-50.00%-51.56%-54.41%-24.39%-76.87%

Ownership & Short Interest

Insider Ownership i 20.24%
Institutional Ownership i 8.38%
Shares Short i N/A
Short Ratio i N/A
Short % of Shares Outstanding i N/A
Average 10-Day Volume i 707K
Average 90-Day Volume i 401K

Adocia S.A Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Adocia S.A would have performed over time.

If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

In the last 52 weeks, Adocia S.A reached a high of €10.96 (on November 4, 2024) and a low of €2.86 (on April 7, 2025).
Curious about Adocia S.A's size and valuation? Its market capitalization stands at 126.07M. When it comes to valuation, the P/E ratio (trailing twelve months) is -6.69, and the forward P/E (looking ahead) is -4.99.
As for dividends, Adocia S.A isn't currently offering a significant yield, or that specific data isn't available right now.

When looking at Adocia S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
Abivax SA
ABVX
4.49BHealthcareBiotechnology473.06%570.37%
Valneva SE
VLA
546.93MHealthcareBiotechnology21.86%-62.51%
Ose
OSE
136.49MHealthcareBiotechnology-14.41%-15.60%
Transgene S.A
TNG
133.40MHealthcareBiotechnology0.00%-54.95%
Sensorion SA
ALSEN
98.61MHealthcareBiotechnology-54.41%-24.39%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

To get a sense of Adocia S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 301.75%, the Debt to Equity ratio from the most recent quarter is -3.83, and its Gross Profit Margin stands at N/A.
Looking at Adocia S.A's growth, its revenue over the trailing twelve months (TTM) was €12M. Compared to the same quarter last year (YoY), quarterly revenue grew by 397.20%, and quarterly earnings saw a YoY growth of N/A.
Wondering who owns Adocia S.A stock? Company insiders (like executives and directors) hold about 20.24% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 8.38%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.